Arena Pharmaceuticals Inc (ARNA.OQ)
BRIEF-Arena Pharma, Everest Medicines Enter Into Development And Commercialization Partnership For Ralinepag And Etrasimod In China
* ARENA PHARMACEUTICALS AND EVEREST MEDICINES ENTER INTO DEVELOPMENT AND COMMERCIALIZATION PARTNERSHIP FOR RALINEPAG AND ETRASIMOD IN CHINA
* Arena Pharmaceuticals provides corporate update and reports third quarter 2017 financial results
* Arena Pharmaceuticals provides corporate update and reports second quarter 2017 financial results
* Arena Pharmaceuticals announces pricing of public offering of common stock
* Arena Pharmaceuticals announces proposed public offering of common stock
U.S. drug developer Arena Pharmaceuticals Inc said on Monday its experimental drug for pulmonary arterial hypertension (PAH), a rare but deadly lung disease, met the main goal in a mid-stage study.